Assignee
FRASER CHRISTOPHER
US·5 granted patents·1 pending application·142 citations·filing 2011–2012
Top patents by PatentIndex Score
6 records- 0196US9987354B2Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cellsFRASER CHRISTOPHER·Filed 2012·Granted Jun 5, 2018·29 cites·16 claims
- 0296US9295718B2Tolerogenic synthetic nanocarriers to reduce immune responses to therapeutic proteinsFRASER CHRISTOPHER·Filed 2012·Granted Mar 29, 2016·33 cites·14 claims
- 0396US9289477B2Tolerogenic synthetic nanocarriers to reduce cytotoxic T lymphocyte responsesFRASER CHRISTOPHER·Filed 2012·Granted Mar 22, 2016·30 cites·12 claims
- 0494US9265815B2Tolerogenic synthetic nanocarriersFRASER CHRISTOPHER·Filed 2012·Granted Feb 23, 2016·50 cites·10 claims
- 0563US8754199B2Tango 240 nucleic acids and uses thereofFRASER CHRISTOPHER·Filed 2012·Granted Jun 17, 2014·0 cites·7 claims
- 0638US2012070493A1Targeted multi-epitope dosage forms for induction of an immune response to antigensFRASER CHRISTOPHER·Filed 2011·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →